Why is "Autosomal dominant polycystic kidney disease" trending?

Search Interest Perspective

• Effect of tolvaptan on the prognosis of patients with rapidly progressive autosomal dominant polycystic kidney disease: a prospective open-label study - Frontiers
• A Review of the Management of Nephrolithiasis in Autosomal Dominant Polycystic Kidney Disease - Cureus
• Machine learning for predicting CKD stages in patients with autosomal dominant polycystic kidney disease: a nationwide cohort study in Japan - Nature
• Peritoneal dialysis safe for patients with autosomal dominant polycystic kidney disease - Healio
• Autosomal Dominant Polycystic Kidney Disease Market Set - openPR.com
• OBGYN - Wiley
• Duodenal diverticulum in autosomal dominant polycystic kidney disease - Via Medica Journals
• Calico Life Sciences Announces U.S. FDA Fast Track Designation for Investigational Treatment of Autosomal Dominant Polycystic Kidney Disease - PR Newswire
• Demand for Autosomal Dominant Polycystic Kidney Disease Treatment in USA | Global Market Analysis Report - 2035 - Future Market Insights
• Mayo Clinic uses gene editing to reverse inherited kidney disease in preclinical study - Mayo Clinic News Network
• Calico Life Sciences Announces U.S. FDA Orphan Drug Designation for Investigational Treatment of Autosomal Dominant Polycystic Kidney Disease - Yahoo Finance
• Natural history of simple and complex cysts in autosomal dominant polycystic kidney disease on MRI - Nature
• Molecular Diagnosis and Identification of a Novel Pathogenic Variant in Autosomal Dominant Polycystic Kidney Disease (ADPKD): A Case in Full Bloom - Cureus
• Multi-Target Effects of Novel Synthetic Indanedione-Based Spirotransdicalinol Compound 4l in Autosomal Dominant Polycystic Kidney Disease - Wiley
• SGLT2 inhibitors may slow eGFR decline in autosomal dominant polycystic kidney disease - Healio
• Differences in gut microbiome between autosomal dominant polycystic kidney disease with and without intracranial aneurysms - Nature
• Idiopathic Pubic Symphysis Diastasis in a Patient With Autosomal Dominant Polycystic Kidney Disease: A Rare Case Report - Cureus
• Correction: Targeting TRPM3 as a potential therapeutic approach for autosomal dominant polycystic kidney disease - Nature
• Combined Preimplantation Genetic Testing for Aneuploidy (PGT-A) and Monogenic Disorders (PGT-M) to Prevent Autosomal Dominant Polycystic Kidney Disease After Kidney Transplant - Cureus
• Reliability of radiomic analysis on multiparametric MRI for patients affected by autosomal dominant polycystic kidney disease - Nature
• Integrated review of intracranial aneurysms in autosomal dominant polycystic kidney disease (ADPKD) — novel approaches and emerging perspectives | Buchajewicz | Renal Disease and Transplantation Forum - Via Medica Journals
• Renasant Bio Launches to Pioneer Next-Generation Disease-Modifying Small Molecule Treatments for ADPKD - BioSpace
• Cyst-ine Chapel: Renasant Bio Launches to Solve Complex Kidney Disease ADPKD - Inside Precision Medicine
• Effects of Pravastatin on Kidney Outcomes in Adults With ADPKD - Docwire News
• Using Gene Editing to Tackle the Hereditary Kidney Disease ADPKD - bihealth.org
• Prescribed Water Intake in Autosomal Dominant Polycystic Kidney Disease - NEJM Evidence
• Diagnosis of Autosomal Dominant Polycystic Kidney Disease in a 66-Year-Old Patient With a Genotype-Phenotype Mismatch - Cureus
• Tolvaptan in Later-Stage Autosomal Dominant Polycystic Kidney Disease - The New England Journal of Medicine
• Defining cellular complexity in human autosomal dominant polycystic kidney disease by multimodal single cell analysis - Nature
• Targeting TRPM3 as a potential therapeutic approach for autosomal dominant polycystic kidney disease - Nature
• Monkeys mutant for PKD1 recapitulate human autosomal dominant polycystic kidney disease - Nature
• Echocardiographic characteristics of autosomal dominant polycystic kidney disease - Nature
• Multiscale and multimodal evaluation of autosomal dominant polycystic kidney disease development - Nature
• Modulating inflammation with interleukin 37 treatment ameliorates murine Autosomal Dominant Polycystic Kidney Disease - ScienceDirect.com
• Emerging therapies for autosomal dominant polycystic kidney disease with a focus on cAMP signaling - Frontiers
• Metabolic profiling in children and young adults with autosomal dominant polycystic kidney disease - Nature
• New tool measures pain severity specific to autosomal dominant polycystic kidney disease - Healio
• Somatic mutation in autosomal dominant polycystic kidney disease revealed by deep sequencing human kidney cysts - Nature
• Regulus Therapeutics Announces Positive Clinical and Regulatory Updates from its Autosomal Dominant Polycystic Kidney Disease (ADPKD) Program for Farabursen (RGLS8429) - PR Newswire
• International consensus statement on the diagnosis and management of autosomal dominant polycystic kidney disease in children and young people - Nature
• Diagnosing autosomal dominant polycystic kidney disease - Healio
• Novartis emerged victorious in multi-month pursuit of Regulus and potential kidney blockbuster, filing shows - Fierce Pharma
• Bardoxolone Gets Orphan Drug Status for Autosomal Dominant Polycystic Kidney Disease - Renal and Urology News
• Autosomal Dominant Polycystic Kidney Disease - The New England Journal of Medicine
• A Rare Coexisting Presentation of Autosomal Dominant Polycystic Kidney Disease With Rapid Deterioration of Renal Function and Neurofibromatosis Type 1 - Cureus
• Vicente Torres, M.D., Ph.D., discusses new findings on tolvaptan as autosomal dominant polycystic kidney disease treatment - Mayo Clinic News Network
• Genetic Characteristics of Korean Patients with Autosomal Dominant Polycystic Kidney Disease by Targeted Exome Sequencing - Nature
• Tolvaptan in Patients with Autosomal Dominant Polycystic Kidney Disease - The New England Journal of Medicine
• Extracellular vesicles and exosomes generated from cystic renal epithelial cells promote cyst growth in autosomal dominant polycystic kidney disease - Nature
• ADPKD Outcomes Differ by Race - Renal and Urology News
• Identification of pathological transcription in autosomal dominant polycystic kidney disease epithelia - Nature
• Water Intake in Patients with Autosomal Dominant Polycystic Kidney Disease - Docwire News
• Racial disparities exist among patients with autosomal dominant polycystic kidney disease - Healio
• Blood Pressure in Early Autosomal Dominant Polycystic Kidney Disease - The New England Journal of Medicine
• Next-generation sequencing for detection of somatic mosaicism in autosomal dominant polycystic kidney disease - ScienceDirect.com
• Impact of kidney function and kidney volume on intracranial aneurysms in patients with autosomal dominant polycystic kidney disease | Scientific Reports - Nature
• Regulus Therapeutics Announces Successful Completion of its Phase 1b Multiple-Ascending Dose (MAD) Clinical Trial of Farabursen (RGLS8429) for the Treatment of Autosomal Dominant Polycystic Kidney Disease (ADPKD) - PR Newswire
• Super-enhancer-driven metabolic reprogramming promotes cystogenesis in autosomal dominant polycystic kidney disease - Nature
• Sirolimus and Kidney Growth in Autosomal Dominant Polycystic Kidney Disease - The New England Journal of Medicine
• Overview of clinical status, treatment, and long-term outcomes of pediatric autosomal-dominant polycystic kidney disease: a nationwide survey in Taiwan - Nature
• Neera Dahl, MD, Identifies how to Diagnose Autosomal Dominant Polycystic Kidney Disease - HCPLive
• Prognosis of Vascular Access in Haemodialysis Patients with Autosomal Dominant Polycystic Kidney Disease - Nature
• AI Can Improve Autosomal Dominant Polycystic Kidney Disease Diagnosis & Management - Physician's Weekly
• Chromatin Methylation Abnormalities in Autosomal Dominant Polycystic Kidney Disease - Frontiers
• Ttc21b deficiency attenuates autosomal dominant polycystic kidney disease in a kidney tubular- and maturation-dependent manner - ScienceDirect.com
• Novartis acquires Regulus Therapeutics and potential first-in-class therapeutic - European Medical Journal
• Ciliary exclusion of Polycystin-2 promotes kidney cystogenesis in an autosomal dominant polycystic kidney disease model - Nature
• Extensive Inter-Cyst DNA Methylation Variation in Autosomal Dominant Polycystic Kidney Disease Revealed by Genome Scale Sequencing - Frontiers
• Myofibroblast depletion reduces kidney cyst growth and fibrosis in autosomal dominant polycystic kidney disease - ScienceDirect.com
• Metabolism-based approaches for autosomal dominant polycystic kidney disease - Frontiers
• Cinacalcet may suppress kidney enlargement in hemodialysis patients with autosomal dominant polycystic kidney disease | Scientific Reports - Nature
• Regulus Therapeutics Presents Additional Data from its Autosomal Dominant Polycystic Kidney Disease (ADPKD) Program at PKD Connect 2021 - PR Newswire
• Autosomal Dominant Polycystic Kidney Disease - Consultant360
• Lupin intros generic Jynarque - Drug Store News
• Implications of early diagnosis of autosomal dominant polycystic kidney disease: A post hoc analysis of the TEMPO 3:4 trial - Nature
• Higher prevalence of aneurysms found with autosomal dominant polycystic kidney disease - Healio
• FDA Grants ODD to AP303 for Treatment of Patients With Autosomal Dominant Polycystic Kidney Disease - Pharmacy Times
• US IND clearance for VX-407 for autosomal dominant polycystic kidney disease - BioWorld MedTech
• MRI in autosomal dominant polycystic kidney disease - Zhang - 2019 - Journal of Magnetic Resonance Imaging - onlinelibrary.wiley.com
• Inhibition of Hedgehog signaling suppresses proliferation and microcyst formation of human Autosomal Dominant Polycystic Kidney Disease cells - Nature
• Epidemiology of Autosomal Dominant Polycystic Kidney Disease in the United States – College of Pharmacy - The University of Rhode Island
• Global analysis of urinary extracellular vesicle small RNAs in autosomal dominant polycystic kidney disease - onlinelibrary.wiley.com
• CT of Kidney Volume in Autosomal Dominant Polycystic Kidney Disease: Accuracy, Reproducibility, and Radiation Dose - RSNA Journals
• Marfan Syndrome and Autosomal Dominant Polycystic Kidney Disease: A Case of Rare Co-occurrence or Coincidence? - European Medical Journal
• Bilateral Laparoscopic Nephrectomy in Autosomal Dominant Polycystic Kidney Disease with Bilateral Renal Masses: A Feasible Option - Mary Ann Liebert, Inc.
• Plant-derived compounds for treating autosomal dominant polycystic kidney disease - Frontiers
• Activation of NRF2 ameliorates oxidative stress and cystogenesis in autosomal dominant polycystic kidney disease - Science | AAAS
• DEN Open | JGES Endscopy Journal - onlinelibrary.wiley.com
• Restoration of atypical protein kinase C ζ function in autosomal dominant polycystic kidney disease ameliorates disease progression - PNAS
• 18F-FDG PET/CT in Autosomal Dominant Polycystic Kidney Disease Patients with Suspected Cyst Infection - jnm.snmjournals.org
• 18F-FDG PET/CT in Autosomal Dominant Polycystic Kidney Disease Patients with Suspected Cyst Infection - jnm.snmjournals.org
• Isolated Persistent Left Superior Vena Cava Associated With Autosomal Dominant Polycystic Kidney Disease (ADPKD): Challenges and Clinical Significance - Cureus
• Asymptomatic pyuria acts as a predictor of autosomal dominant polycystic kidney disease - Healio
• Autosomal Dominant Polycystic Kidney Disease (ADPKD): Protective Role of a Potassium Channel - Genetic Engineering and Biotechnology News
• Autosomal Dominant Polycystic Kidney Disease - The New England Journal of Medicine
• Pkd2, mutations linking to autosomal dominant polycystic kidney disease, localizes to the endoplasmic reticulum and regulates calcium signaling in fission yeast - onlinelibrary.wiley.com
• Novel method for the genomic analysis of PKD1 mutation in autosomal dominant polycystic kidney disease - Frontiers
• Metabolomic profiling to identify early urinary biomarkers and metabolic pathway alterations in autosomal dominant polycystic kidney disease - American Physiological Society Journal
• A Case of New Familiar Genetic Variant of Autosomal Dominant Polycystic Kidney Disease-2: A Case Study - Frontiers
• Everolimus in Patients with Autosomal Dominant Polycystic Kidney Disease - The New England Journal of Medicine